Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7516 AL 7530

Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease

Kaur V, Sunkaria A.

Behav Brain Res. 2025 Apr 27;484:115505. doi: 10.1016/j.bbr.2025.115505. Epub 2025 Feb 25.

The Potential Mechanism and the Role of Antioxidants in Mitigating Oxidative Stress in Alzheimer's Disease

Naik RA, Mir MN, Malik IA, Bhardwaj R, Alshabrmi FM, Mahmoud MA, Alhomrani M, Alamri AS, Alsanie WF, Hjazi A, Ghatak T, Poeggeler B, Singh MP, Ts G, Singh SK.

Front Biosci (Landmark Ed). 2025 Feb 18;30(2):25551. doi: 10.31083/FBL25551.

Cognitive resilience in Alzheimer's disease: Mechanism and potential clinical intervention

Jia B, Xu Y, Zhu X.

Ageing Res Rev. 2025 Apr;106:102711. doi: 10.1016/j.arr.2025.102711. Epub 2025 Feb 26.

Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery

Alsaleem MA, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alrouji M, Al-Harchan NA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.

J Cell Mol Med. 2025 Mar;29(5):e70378. doi: 10.1111/jcmm.70378.

[Neurobiological potential of astragaloside IV and prospects for its use in the treatment of Alzheimer's disease]

Berezutsky MA, Durnova NA, Kurchatova MN, Matvienko UA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(2):7-12. doi: 10.17116/jnevro20251250217.

Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective

Bobbins A, Davies M, Lynn E, Roy D, Yeomans A, Shakir SAW.

Br J Clin Pharmacol. 2025 May;91(5):1352-1360. doi: 10.1002/bcp.70021. Epub 2025 Mar 6.

Bioactive peptides as multipotent molecules bespoke and designed for Alzheimer's disease

Mesias A, Borges S, Pintado M, Baptista-Silva S.

Neuropeptides. 2025 Jun;111:102515. doi: 10.1016/j.npep.2025.102515. Epub 2025 Mar 4.

Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies

Dahiya M, Yadav M, Goyal C, Kumar A.

Inflammopharmacology. 2025 Apr;33(4):1817-1831. doi: 10.1007/s10787-025-01704-2. Epub 2025 Mar 10.

Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of Alzheimer's disease: A review

Zaater MA, El Kerdawy AM, Mahmoud WR, Abou-Seri SM.

Int J Biol Macromol. 2025 May;307(Pt 3):142141. doi: 10.1016/j.ijbiomac.2025.142141. Epub 2025 Mar 14.

Ferroptosis and Alzheimer's: unveiling new avenues for the treatment and prevention

Sharma V, Sharma P, Singh TG.

Metab Brain Dis. 2025 Apr 1;40(4):167. doi: 10.1007/s11011-025-01587-w.

Knowledge and Attitude of Nurses in Wuxi, China Towards Alzheimer's Disease: A Cross-Sectional Study

Wang R, Gu Y, Yang H, Ge S, Cai Y, Wan X.

Nurs Open. 2025 Apr;12(4):e70199. doi: 10.1002/nop2.70199.

The endocannabinoid system offers a target for Alzheimer's disease treatment through inhibition of fatty acid amide hydrolase (FAAH)

de Ceballos ML.

FEBS J. 2025 Aug;292(16):4156-4159. doi: 10.1111/febs.70082. Epub 2025 Apr 2.

Therapeutic modulation of neurogenesis to improve hippocampal plasticity and cognition in aging and Alzheimer's disease

Mostafa M, Disouky A, Lazarov O.

Neurotherapeutics. 2025 Apr;22(3):e00580. doi: 10.1016/j.neurot.2025.e00580. Epub 2025 Apr 2.

Anticholinesterases Traits Inbuilt in Buxaceae Plant Extracts against Alzheimer's Disease

Patocka J, Sharma S, Navratilova Z, Singh N, Jelinkova R, Mehboob N, Oleksak P, Nepovimova E, Kuca K.

Curr Neuropharmacol. 2025;23(10):1137-1155. doi: 10.2174/1570159X23666250326091016.

Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids

Yavari M, Kalupahana NS, Harris BN, Ramalingam L, Zu Y, Kahathuduwa CN, Moustaid-Moussa N.

Nutrients. 2025 Mar 29;17(7):1203. doi: 10.3390/nu17071203.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias